Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma

Oncogene

Volumn 29, Issue 1, 2010, Pages 81-92

  Keenen, B ^a   Qi, H ^a   Saladi, S V ^a   Yeung, M ^a   De La Serna, I L ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

BRG1; Chromatin; Differentiation; Melanoma; MITF; SWI SNF

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BRM PROTEIN; CISPLATIN; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; PROTEIN SWI; TRANSCRIPTION FACTOR SNF;

ARTICLE; CARCINOGENICITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL NUCLEUS; CELLS, CULTURED; CHROMOSOMAL PROTEINS, NON-HISTONE; CISPLATIN; DNA HELICASES; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; MELANOMA; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 73849126977     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.304     Document Type: Article

References (54)

1. Bandyopadhyay D, Curry JL, Lin Q, Richards HW, Chen D, Hornsby PJ et al. (2007). Dynamic assembly of chromatin complexes during cellular senescence: implications for the growth arrest of human melanocytic nevi. Aging Cell 6: 577-591.
2. Becker TM, Haferkamp S, Dijkstra MK, Scurr LL, Frausto M, Diefenbach E et al. (2009). The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16INK4a. Mol Cancer 8: 4.
3. Caramel J, Medjkane S, Quignon F, Delattre O. (2008). The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors. Oncogene 27: 2035-2044.
4. Carreira S, Goodall J, Aksan I, La Rocca SA, Galibert MD, Denat L et al. (2005). Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression. Nature 433: 764-769.
5. Carreira S, Goodall J, Denat L, Rodriguez M, Nuciforo P, Hoek KS et al. (2006). Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev 20: 3426-3439.
6. Carreira S, Liu B, Goding CR. (2000). The gene encoding the T-box factor Tbx2 is a target for the microphthalmia-associated transcription factor in melanocytes. J Biol Chem 275: 21920-21927.
7. Chen J, Archer TK. (2005). Regulating SWI/SNF subunit levels via protein-protein interactions and proteasomal degradation: BAF155 and BAF170 limit expression of BAF57. Mol Cell Biol 25: 9016-9027.
8. Chen KG, Valencia JC, Lai B, Zhang G, Paterson JK, Rouzaud F et al. (2006). Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomas. Proc Natl Acad Sci USA 103: 9903-9907.
9. Chiaverini C, Beuret L, Flori E, Busca R, Abbe P, Bille K et al. (2008). Microphthalmia-associated transcription factor regulates RAB27A gene expression and controls melanosome transport. J Biol Chem 283: 12635-12642.
10. Chu W, Pak BJ, Bani MR, Kapoor M, Lu SJ, Tamir A et al. (2000). Tyrosinase-related protein 2 as a mediator of melanoma specific resistance to cis-diamminedichloroplatinum(II): therapeutic implications. Oncogene 19: 395-402.
11. de La Serna IL, Carlson KA, Hill DA, Guidi CJ, Stephenson RO, Sif S et al. (2000). Mammalian SWI-SNF complexes contribute to activation of the hsp70 gene. Mol Cell Biol 20: 2839-2851.
12. de la Serna IL, Ohkawa Y, Berkes CA, Bergstrom DA, Dacwag CS, Tapscott SJ et al. (2005). MyoD targets chromatin remodeling complexes to the myogenin locus prior to forming a stable DNA-bound complex. Mol Cell Biol 25: 3997-4009.
13. de la Serna IL, Ohkawa Y, Higashi C, Dutta C, Osias J, Kommajosyula N et al. (2006a). The microphthalmia-associated transcription factor (MITF) requires SWI/SNF enzymes to activate melanocyte specific genes. J Biol Chem 281: 20233-20241.
14. de la Serna IL, Ohkawa Y, Imbalzano AN. (2006b). Chromatin remodelling in mammalian differentiation: lessons from ATP-dependent remodellers. Nat Rev Genet 7: 461-473.
15. de la Serna IL, Roy K, Carlson KA, Imbalzano AN. (2001). MyoD can induce cell cycle arrest but not muscle differentiation in the presence of dominant negative SWI/SNF chromatin remodeling enzymes. J Biol Chem 276: 41486-41491.
16. Decristofaro MF, Betz BL, Rorie CJ, Reisman DN, Wang W, Weissman BE. (2001). Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies. J Cell Physiol 186: 136-145.
17. Du J, Widlund HR, Horstmann MA, Ramaswamy S, Ross K, Huber WE et al. (2004). Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF. Cancer Cell 6: 565-576.
18. Dunaief JL, Strober BE, Guha S, Khavari PA, Alin K, Luban J et al. (1994). The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell 79: 119-130.
19. Dynek JN, Chan SM, Liu J, Zha J, Fairbrother WJ, Vucic D. (2008). Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas. Cancer Res 68: 3124-3132.
20. Eberle J, Garbe C, Wang N, Orfanos CE. (1995). Incomplete expression of the tyrosinase gene family (tyrosinase, TRP-1, and TRP-2) in human malignant melanoma cells in vitro. Pigment Cell Res 8: 307-313.
21. Flowers S, Nagl Jr NG, Beck Jr GR, Moran E. (2009). Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation. J Biol Chem 284: 10067-10075.
22. Fukuoka J, Fujii T, Shih JH, Dracheva T, Meerzaman D, Player A et al. (2004). Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer. Clin Cancer Res 10: 4314-4324.
23. Garraway LA, Sellers WR. (2006). Lineage dependency and lineage-survival oncogenes in human cancer. Nat Rev Cancer 6: 593-602.
24. Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S et al. (2005). Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436: 117-122.
25. Gartel AL, Tyner AL. (1999). Transcriptional regulation of the p21((WAF1/CIP1)) gene. Exp Cell Res 246: 280-289.
26. Gong F, Fahy D, Liu H, Wang W, Smerdon MJ. (2008). Role of the mammalian SWI/SNF chromatin remodeling complex in the cellular response to UV damage. Cell Cycle 7: 1067-1074.
27. Gong F, Fahy D, Smerdon MJ. (2006). Rad4-Rad23 interaction with SWI/SNF links ATP-dependent chromatin remodeling with nucleo-tide excision repair. Nat Struct Mol Biol 13: 902-907.
28. Hemesath TJ, Steingrimsson E, McGill G, Hansen MJ, Vaught J, Hodgkinson CA et al. (1994). microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev 8: 2770-2780.
29. Hoek K, Rimm DL, Williams KR, Zhao H, Ariyan S, Lin A et al. (2004). Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res 64: 5270-5282.
30. Kadam S, McAlpine GS, Phelan ML, Kingston RE, Jones KA, Emerson BM. (2000). Functional selectivity of recombinant mammalian SWI/SNF subunits. Genes Dev 14: 2441-2451.
31. Kang H, Cui K, Zhao K. (2004). BRG1 controls the activity of the retinoblastoma protein via regulation of p21CIP1/WAF1/SDI. Mol Cell Biol 24: 1188-1199.
32. Levy C, Khaled M, Fisher DE. (2006). MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol Med 12: 406-414.
33. Link KA, Balasubramaniam S, Sharma A, Comstock CE, Godoy-Tundidor S, Powers N et al. (2008). Targeting the BAF57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity. Cancer Res 68: 4551-4558.
34. Link KA, Burd CJ, Williams E, Marshall T, Rosson G, Henry E et al. (2005). BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF. Mol Cell Biol 25: 2200-2215.
35. Loercher AE, Tank EM, Delston RB, Harbour JW. (2005). MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A. J Cell Biol 168: 35-40.
36. Machida Y, Murai K, Miyake K, Iijima S. (2001). Expression of chromatin remodeling factors during neural differentiation. J Biochem (Tokyo) 129: 43-49.
37. McGill GG, Horstmann M, Widlund HR, Du J, Motyckova G, Nishimura EK et al. (2002). Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 109: 707-718.
38. Nagl Jr NG, Wang X, Patsialou A, Van Scoy M, Moran E. (2007). Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control. EMBO J 26: 752-763.
39. Pak BJ, Li Q, Kerbel RS, Ben-David Y. (2000). TYRP2-mediated resistance to cis-diamminedichloroplatinum (II) in human melanoma cells is independent of tyrosinase and TYRP1 expression and melanin content. Melanoma Res 10: 499-505.
40. Park JH, Park EJ, Hur SK, Kim S, Kwon J. (2009). Mammalian SWI/ SNF chromatin remodeling complexes are required to prevent apoptosis after DNA damage. DNA Repair (Amst) 8: 29-39.
41. Park JH, Park EJ, Lee HS, Kim SJ, Hur SK, Imbalzano AN et al. (2006). Mammalian SWI/SNF complexes facilitate DNA double-strand break repair by promoting gamma-H2AX induction. EMBO J 25: 3986-3997.
42. Pollack MS, Heagney SD, Livingston PO, Fogh J. (1981). HLA-A, B, C and DR alloantigen expression on forty-six cultured human tumor cell lines. J Natl Cancer Inst 66: 1003-1012. (Pubitemid 11063895)
43. Ramirez-Carrozzi VR, Nazarian AA, Li CC, Gore SL, Sridharan R, Imbalzano AN et al. (2006). Selective and antagonistic functions of SWI/SNF and Mi-2beta nucleosome remodeling complexes during an inflammatory response. Genes Dev 20: 282-296.
44. Reisman DN, Sciarrotta J, Wang W, Funkhouser WK, Weissman BE. (2003). Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis. Cancer Res 63: 560-566.
45. Rosson GB, Bartlett C, Reed W, Weissman BE. (2005). BRG1 loss in MiaPaCa2 cells induces an altered cellular morphology and disruption in the organization of the actin cytoskeleton. J Cell Physiol 205: 286-294.
46. Shen L, Kondo Y, Ahmed S, Boumber Y, Konishi K, Guo Y et al. (2007). Drug sensitivity prediction by CpG island methylation profile in the NCI-60 cancer cell line panel. Cancer Res 67: 11335-11343.
47. Sif S. (2004). ATP-dependent nucleosome remodeling complexes: enzymes tailored to deal with chromatin. J Cell Biochem 91: 1087-1098.
48. Svensson SP, Lindgren S, Powell W, Green H. (2003). Melanin inhibits cytotoxic effects of doxorubicin and daunorubicin in MOLT 4 cells. Pigment Cell Res 16: 351-354.
49. Versteege I, Sevenet N, Lange J, Rousseau-Merck MF, Ambros P, Handgretinger R et al. (1998). Truncating mutations of hSNF5/ INI1 in aggressive paediatric cancer. Nature 394: 203-206.
50. Vink J, Thomas L, Etoh T, Bruijn JA, Mihm Jr MC, Gattoni-Celli S et al. (1993). Role of beta-1 integrins in organ specific adhesion of melanoma cells in vitro. Lab Invest 68: 192-203.
51. Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR. (2008). Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 132: 363-374.
52. Wang L, Baiocchi RA, Pal S, Mosialos G, Caligiuri M, Sif S. (2005). The BRG1-and hBRM-associated factor BAF57 induces apoptosis by stimulating expression of the cylindromatosis tumor suppressor gene. Mol Cell Biol 25: 7953-7965.
53. Xu Y, Zhang J, Chen X. (2007). The activity of p53 is differentially regulated by Brm-and Brg1-containing SWI/SNF chromatin remodeling complexes. J Biol Chem 282: 37429-37435.
54. Yamamichi N, Inada K, Ichinose M, Yamamichi-Nishina M, Mizutani T, Watanabe H et al. (2007). Frequent loss of Brm expression in gastric cancer correlates with histologic features and differentiation state. Cancer Res 67: 10727-10735.